Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer

Cancer Journal

Volumn 7, Issue 2, 2001, Pages 140-148

  Mantz, C A ^a   Vokes, E E ^a   Stenson, K ^a   Kies, M S ^a   Mittal, B ^a   Witt, M E ^a   List, M A ^a   Weichselbaum, R R ^a   Haraf, D J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chemoradiotherapy; Chemotherapy; Oropharyngeal cancer

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OROPHARYNX CANCER; PRIORITY JOURNAL; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; HYDROXYUREA; INTERFERON ALFA-2B; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OROPHARYNGEAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035045010     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Head and neck cancer
2. Cancer of the head and neck
3. Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience
4. A multivariate primary tumour control analysis in 465 patients treated with radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors
5. External beam irradiation alone or combined with neck dissection for base of tongue carcinoma: An alternative to primary surgery
6. Carcinoma of the tonsillar fossa: A nonrandomized comparison of irradiation alone or combined with surgery: Long-term results
7. Squamous cell carcinoma of the base of tongue
8. Preoperative irradiation and surgery for carcinoma of the base of tongue
9. Performance status after treatment for squamous cell cancer of the base of tongue: A comparison of primary radiation therapy versus primary surgery
10. Quality of life outcomes after primary radiotherapy for squamous cell carcinoma of the base of tongue
11. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival
12. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease
13. Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer
14. Organ-function preservation in advanced oropharynx cancer: Results with induction chemotherapy and radiation
15. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M.D. Anderson Cancer Center experience
16. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
17. Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-Year analysis of results
18. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
19. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
20. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
21. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma
22. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
23. Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer
24. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: A clinical and pharmacologic analysis
25. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: A phase I-II study
26. Favorable long-term survival following induction chemotherapy with PFL and concomitant chemoradiotherapy for locally advanced head and neck cancer
27. Nonparametric estimation from incomplete observations
28. Evaluation of survival data and two new rank order statistics arising in its consideration
29. Regression Models and lifetables
30. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
31. Improved local control for advanced oropharyngeal carcinoma following twice daily radiation therapy
32. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays
33. Relationship between fluorouracil systemic exposure and tumor response and patient survival
34. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program
35. Fractionation with x-rays and neutrons in mice: Response of skin and C3H mammary tumours
36. The hazard of accelerated tumor clonogen repopulation during radiotherapy
37. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation
38. Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer